Company Filing History:
Years Active: 2007
Title: Kiyoshige Hatta: Innovator in Antiviral Peptide Development
Introduction
Kiyoshige Hatta is a notable inventor based in Ebetsu, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antiviral agents. His work focuses on peptides that exhibit antiviral activity, showcasing his innovative approach to addressing health challenges.
Latest Patents
Hatta holds a patent for "Peptides, derivatives thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient." This patent includes peptides with specific amino acid compositions, which have demonstrated antiviral properties. The peptides consist of various combinations of glutamine, glutamic acid, serine, valine, isoleucine, and leucine residues, all linked to a hydroxydecanoyl or hydroxydodec-5-enoyl group. This innovative work highlights the potential of these peptides in developing effective antiviral treatments.
Career Highlights
Kiyoshige Hatta is associated with Toyo Suisan Kaisha, Ltd., where he has been instrumental in advancing research in peptide technology. His dedication to innovation has led to the successful development of a strain capable of producing the aforementioned peptides, contributing to the company's reputation in the biotechnology sector.
Collaborations
Hatta has collaborated with notable colleagues, including Masahiro Ishima and Tsutomu Yoshida. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of antiviral agents.
Conclusion
Kiyoshige Hatta's contributions to peptide research and antiviral development underscore his role as a leading inventor in biotechnology. His innovative work continues to pave the way for advancements in health solutions.